Loading clinical trials...
Loading clinical trials...
The primary objective is to examine the efficacy of 8-weeks of a locally developed brain-computer interface based system intervention for improving attention and memory in healthy elderly and those wi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Duke-NUS Graduate Medical School
Collaborators
NCT07033494 · Early Alzheimer's Disease
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
NCT06159673 · Alzheimer's Disease Psychosis
NCT07220668 · Mild Cognitive Impairment
Duke-NUS Medical School
Singapore
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions